๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Omeprazole - Medicines in Ireland

26 authorised products containing Omeprazole, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 26 authorised medicines
MedicineActive substanceLicence holderStatus
Appizped 10mg/15ml oral solution
PA22784/001/001
Omeprazole Proveca Pharma Limited Not marketed
Appizped 20 mg/15ml oral solution
PA22784/001/002
Omeprazole Proveca Pharma Limited Not marketed
Losec MUPS 10 mg gastro-resistant tablets
PPA0465/423/003
Omeprazole PCO Manufacturing Ltd. Marketed
Losec MUPS 10 mg gastro-resistant tablets
PPA1463/141/002
Omeprazole IMED Healthcare Ltd., โ€”
Losec MUPS 20 mg gastro-resistant tablets
PPA0465/423/001
Omeprazole PCO Manufacturing Ltd. โ€”
Losec MUPS 20 mg gastro-resistant tablets
PPA1463/141/001
Omeprazole IMED Healthcare Ltd., โ€”
Loseina 10 mg hard gastro-resistant capsules
PA0281/272/001
Omeprazole Pinewood Laboratories Limited Not marketed
Loseina 20 mg hard gastro-resistant capsules
PA0281/272/002
Omeprazole Pinewood Laboratories Limited Marketed
Loseina 40 mg hard gastro-resistant capsules
PA0281/272/003
Omeprazole Pinewood Laboratories Limited Marketed
Omeprazole 10 mg Gastro-resistant Capsules, hard
PA23266/077/001
Omeprazole Viatris Limited Not marketed
Omeprazole 10 mg hard gastro-resistant capsules
PA2315/129/001
Omeprazole Accord Healthcare Ireland Ltd. Marketed
Omeprazole 20 mg Gastro-resistant Capsules, hard
PA23266/077/002
Omeprazole Viatris Limited Not marketed
Omeprazole 20 mg hard gastro-resistant capsules
PA2315/129/002
Omeprazole Accord Healthcare Ireland Ltd. Marketed
Omeprazole 40 mg Gastro-resistant Capsules, hard
PA23266/077/003
Omeprazole Viatris Limited Not marketed
Omeprazole 40 mg hard gastro-resistant capsules
PA2315/129/003
Omeprazole Accord Healthcare Ireland Ltd. Marketed
Omeprazole Bluefish 10 mg gastro-resistant capsules
PA1436/007/001
Omeprazole Bluefish Pharmaceuticals AB Marketed
Omeprazole Bluefish 20 mg gastro-resistant capsules
PA1436/007/002
Omeprazole Bluefish Pharmaceuticals AB Marketed
Omeprazole Bluefish 40 mg gastro-resistant capsules
PA1436/007/003
Omeprazole Bluefish Pharmaceuticals AB Marketed
Omeprazole Pinewood 20 mg gastro-resistant capsules, hard
PA0281/152/001
Omeprazole Pinewood Laboratories Limited Not marketed
Omeprazole Rowa 20 mg Gastro-resistant Capsules, hard
PA0074/075/002
Omeprazole Rowa Pharmaceuticals Limited, Marketed
Omeprazole Rowa 40 mg Gastro-Resistant Capsules, hard
PA0074/075/003
Omeprazole Rowa Pharmaceuticals Limited, Marketed
Omeprazole Teva 10 mg gastro-resistant capsules, hard
PA0749/160/001
Omeprazole Teva Pharma B.V. Marketed
Omeprazole Teva 20 mg gastro-resistant capsules, hard
PA0749/160/002
Omeprazole Teva Pharma B.V. Marketed
Omeprazole Teva 40 mg Gastro-resistant Capsules, hard
PA0749/160/003
Omeprazole Teva Pharma B.V. Marketed
Pedippi 2 mg/ml powder for oral suspension
PA1572/002/001
Omeprazole Xeolas Pharmaceuticals Limited Marketed
Pedippi 4 mg/ml powder for oral suspension
PA1572/002/002
Omeprazole Xeolas Pharmaceuticals Limited Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.